News archive for 2005

Find below ReNeuron's archived press releases for 2005

ReNeuron to present at Harris Nesbitt healthcare conference. 06/12/05

Guildford, UK, 6 December 2005: ReNeuron Group plc (LSE: RENE.L) today announces that it will participate in the Harris Nesbitt 5th Annual Investor …

Read article

ReNeuron welcomes government pledges to support stem cell research and development in the UK. 02/12/05

Guildford, UK, 2 December 2005: ReNeuron Group plc (LSE: RENE.L) has noted the UK government responses to the report and recommendations of the UK …

Read article

ReNeuron Group plc Interim Results for the six months ending September 2005. 30/11/05

Highlights Lead ReN001 stroke therapy progresses to plan, including positive pre-IND meeting with FDAInitial results of late pre-clinical studies show …

Read article

ReNeuron announces first results from key pre-clinical safety studies with its lead ReN001 stem cell line for stroke. 18/11/05

Guildford, UK, 18 November 2005: ReNeuron Group plc (LSE: RENE.L) today announced that it has generated provisional pre-clinical data indicating that …

Read article

ReNeuron Group plc demonstrates key characteristics with its hepatocyte (liver) cell lines for drug discovery applications. 25/10/05

Guildford, UK, 25 October 2005: ReNeuron Group plc (LSE: RENE.L) today announced that it has developed human hepatocyte (liver) cell lines using its …

Read article

ReNeuron Group plc holds key meeting with the FDA regarding its ReN001 stem cell therapy for stroke. 22/09/05

Guildford, UK, 22 September 2005: ReNeuron Group plc (LSE: RENE.L) today announced that it has held a formal pre-IND1 meeting with the CBER2 component …

Read article

ReNeuron Group Plc – Admission to Trading on AIM. 12/08/05

Guildford, UK, 12 August 2005: ReNeuron Group Plc ("ReNeuron" or the "Company") announces that trading in the Company's ordinary shares and warrants …

Read article

ReNeuron Announces Successful Completion of Flotation. 05/08/05

Guildford, UK, 5 August 2005: ReNeuron Group plc ("ReNeuron" or the "Company"), the UK-based adult stem cell company, today announces that it has …

Read article

ReNeuron Announces Intention to List on AIM. 12/07/05

£10 million placing to fund first human stem cell trial in major CNS disease Not for release or distribution or publication in whole or part in …

Read article

ReNeuron enters stem cell cross-licence with StemCells, Inc.. 06/07/05

Guildford, Surrey, UK, July 6 2005: ReNeuron, the UK-based adult stem cell research and development company, announced today that it has entered into …

Read article

ReNeuron comments on research highlighting contamination of certain stem cell lines. 26/01/05

ReNeuron, the UK-based stem cell research and development company, has noted the recent publication in Nature Medicine of findings by US researchers …

Read article

ReNeuron consortium awarded UK grant for stem cell therapy development. 11/01/05

ReNeuron, the UK-based stem cell research and development company, is pleased to announce that a consortium led by it has been awarded a £2.2 …

Read article

Top of page

Back to News